+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hospital-Acquired Pneumonia Prevention Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 229 Pages
  • May 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5972662
With an aging population on the rise worldwide, coupled with a noticeable decline in immunity levels among the elderly, the imperative for hospital-acquired pneumonia prevention has never been more pressing. These dual factors are expected to drive substantial growth in the hospital-acquired pneumonia prevention market over the next few years.

In a recent report released by Fairfield Market Research it was revealed that the global market for hospital-acquired pneumonia prevention is projected to experience robust expansion over the forecast period of 2024-2031. This growth is attributed to several key factors, including the increasing prevalence of chronic diseases, longer hospital stays, and promising industry trends such as medical tourism.

Oral Care Kits: A Cornerstone of Prevention

One of the standout findings of the report is the pivotal role that oral care products and kits are poised to play in the prevention of hospital-acquired pneumonia. With a number of countries mandating the implementation of standardized pneumonia prevention protocols, including rigorous oral care, in ICU and CCU sections, the demand for oral care kits is expected to witness a significant upsurge.

Opportunities Abound in Emerging Economies

The report also highlights the burgeoning opportunities present in emerging economies, particularly in Southeast Asian countries, where the incidence of pneumonia among hospitalized patients is anticipated to escalate in the near future. This expansion of the patient pool, coupled with the increasing adoption of prevention protocols, is expected to drive substantial growth in these regions.

Product Segmentation Insights

In terms of product segmentation, oral care kits emerge as the frontrunner, accounting for a substantial share of the market revenues. This segment is expected to maintain its dominance throughout the forecast period, followed closely by suction tools. Other segments, including swabs, toothbrushes, and mouthwashes, are also projected to contribute significantly to market growth.

Standardized Oral Care Protocols: A Game-Changer

The report also delves into the key findings regarding standardized oral care protocols for hospital-acquired pneumonia patients. It underscores the importance of enhanced oral care for reducing the incidence of non-ventilator-associated hospital-acquired pneumonia, particularly among care-dependent neurologically impaired patients.

Key Market Players Include

  • Sage Products LLC (Stryker Corporation)
  • Intersurgical Ltd.
  • Medline Industries, Inc.
  • Halyard Health, Inc.
  • Others.

Global Male Hypogonadism market is Segmented as Below:

By Product Type

  • Oral Care Kit
  • Toothbrush
  • Swab
  • Moisturizer
  • Mouth Wash
  • Suction Tools

By End-user

  • Hospitals
  • Rehabilitation Centers

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China (APEC)
  • China
  • Middle East & Africa (MEA)
  • Home Care Settings


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Hospital-Acquired Pneumonia Prevention Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
3.1. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Oral Care Kit
3.1.1.2. Toothbrush
3.1.1.3. Swab
3.1.1.4. Moisturizer
3.1.1.5. Mouth Wash
3.1.1.6. Suction Tools
3.2. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Rehabilitation Centers
3.2.1.3. Home Care Settings
3.3. Global Hospital-Acquired Pneumonia Prevention Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
4.1. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Oral Care Kit
4.1.1.2. Toothbrush
4.1.1.3. Swab
4.1.1.4. Moisturizer
4.1.1.5. Mouth Wash
4.1.1.6. Suction Tools
4.2. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Rehabilitation Centers
4.2.1.3. Home Care Settings
4.3. North America Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
5.1. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Oral Care Kit
5.1.1.2. Toothbrush
5.1.1.3. Swab
5.1.1.4. Moisturizer
5.1.1.5. Mouth Wash
5.1.1.6. Suction Tools
5.2. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Rehabilitation Centers
5.2.1.3. Home Care Settings
5.3. Europe Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
6.1. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Oral Care Kit
6.1.1.2. Toothbrush
6.1.1.3. Swab
6.1.1.4. Moisturizer
6.1.1.5. Mouth Wash
6.1.1.6. Suction Tools
6.2. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Rehabilitation Centers
6.2.1.3. Home Care Settings
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
7.1. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Oral Care Kit
7.1.1.2. Toothbrush
7.1.1.3. Swab
7.1.1.4. Moisturizer
7.1.1.5. Mouth Wash
7.1.1.6. Suction Tools
7.2. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospitals
7.2.1.2. Rehabilitation Centers
7.2.1.3. Home Care Settings
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, 2018 - 2031
8.1. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Oral Care Kit
8.1.1.2. Toothbrush
8.1.1.3. Swab
8.1.1.4. Moisturizer
8.1.1.5. Mouth Wash
8.1.1.6. Suction Tools
8.2. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Rehabilitation Centers
8.2.1.3. Home Care Settings
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Hospital-Acquired Pneumonia Prevention Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Hospital-Acquired Pneumonia Prevention Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Sage Products LLC (Stryker Corporation)
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Intersurgical Ltd.
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Medline Industries, Inc.
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Halyard Health, Inc.
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Others
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
10. Appendix
10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations

Companies Mentioned

  • Sage Products LLC (Stryker Corporation)
  • Intersurgical Ltd.
  • Medline Industries, Inc.
  • Halyard Health, Inc.

Methodology

Loading
LOADING...